Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

    Get Diamond plan for FREE

    logo

    Dynatronics Corporation (DYNT)

    Price:

    0.04 USD

    ( - 0 USD)

    Your position:

    0 USD

    ACTION PANEL
    CREATE A NOTE
    ABOUT
    Symbol
    DYNT
    Name
    Dynatronics Corporation
    Industry
    Medical - Devices
    Sector
    Healthcare
    Price
    0.041
    Market Cap
    403.612k
    Enterprise value
    6.975M
    Currency
    USD
    Ceo
    Brian D. Baker
    Full Time Employees
    111
    Ipo Date
    1983-12-01
    City
    Eagan
    Address
    1200 Trapp Road

    Check the

    KEY TAKEAWAYS

    ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)
    Descriptive alt text

    (REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION

    SIMILAR COMPANIES STI SCORE

    Similar STI Score

    Getinge AB (publ)

    VALUE SCORE:

    3

    Symbol
    GNGBF
    Market Cap
    53.313B
    Industry
    Medical - Devices
    Sector
    Healthcare

    2nd position

    Embla Medical hf.

    VALUE SCORE:

    10

    Symbol
    OSSUY
    Market Cap
    1.907B
    Industry
    Medical - Devices
    Sector
    Healthcare

    The best

    Drägerwerk AG & Co. KGaA

    VALUE SCORE:

    11

    Symbol
    DGWPF
    Market Cap
    1.143B
    Industry
    Medical - Devices
    Sector
    Healthcare
    FUNDAMENTALS
    P/E
    -0.049
    P/S
    0.015
    P/B
    0.173
    Debt/Equity
    2.256
    EV/FCF
    86.254
    Price to operating cash flow
    -1.000
    Price to free cash flow
    -1.000
    EV/sales
    0.244
    Earnings yield
    -20.239
    Debt/assets
    0.460
    FUNDAMENTALS
    Net debt/ebidta
    -0.660
    Interest coverage
    -5.606
    Research And Developement To Revenue
    0
    Intangile to total assets
    0.088
    Capex to operating cash flow
    0.288
    Capex to revenue
    0.001
    Capex to depreciation
    0.031
    Return on tangible assets
    -0.785
    Debt to market cap
    17.102
    Piotroski Score
    3.000
    FUNDAMENTALS
    PEG
    -0.010
    P/CF
    4.976
    P/FCF
    5.319
    RoA %
    -71.560
    RoIC %
    -21.681
    Gross Profit Margin %
    21.488
    Quick Ratio
    0.498
    Current Ratio
    1.070
    Net Profit Margin %
    -40.040
    Net-Net
    -0.513
    FUNDAMENTALS PER SHARE
    FCF per share
    0.006
    Revenue per share
    2.057
    Net income per share
    -0.824
    Operating cash flow per share
    0.008
    Free cash flow per share
    0.006
    Cash per share
    0.058
    Book value per share
    0.235
    Tangible book value per share
    0.133
    Shareholders equity per share
    0.235
    Interest debt per share
    0.561
    TECHNICAL
    52 weeks high
    0.168
    52 weeks low
    0.040
    Current trading session High
    0.041
    Current trading session Low
    0.041
    DIVIDEND
    Dividend yield
    0.00%
    Payout ratio
    0.00%
    Years of div. Increase
    0
    Years of div.
    0
    Q-shift
    Dividend per share
    0
    SIMILAR COMPANIES
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Pharmaceuticals
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -7.219
    logo

    Country
    AU
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -34.996
    logo

    Country
    CA
    Sector
    Healthcare
    Industry
    Medical - Healthcare Information Services
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.258
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Drug Manufacturers - Specialty & Generic
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -3.341
    logo

    Country
    CA
    Sector
    Healthcare
    Industry
    Medical - Devices
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.310
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Distribution
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -77.021
    logo

    Country
    CA
    Sector
    Healthcare
    Industry
    Medical - Healthcare Information Services
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.020
    logo

    Country
    CA
    Sector
    Healthcare
    Industry
    Medical - Healthcare Information Services
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.015
    logo

    Country
    CA
    Sector
    Healthcare
    Industry
    Medical - Devices
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -5.087
    logo

    Country
    CA
    Sector
    Healthcare
    Industry
    Drug Manufacturers - Specialty & Generic
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.064
    DESCRIPTION

    Dynatronics Corporation, a medical device company, designs, manufactures, and sells physical therapy, rehabilitation, orthopedics, pain management, and athletic training products in the United States. Its orthopedic soft bracing products include cervical collars, shoulder immobilizers, arm slings, wrist and elbow supports, abdominal and lumbosacral supports, maternity supports, knee immobilizers and supports, ankle walkers and supports, plantar fasciitis splints, and cold therapy products. The company provides therapeutic modality devices comprising electrotherapy, ultrasound, phototherapy, therapeutic lasers, shortwave diathermy, radial pulse therapy, hot and cold therapy, compression therapy, and electrodes. It also offers power and manually operated treatment tables, mat platforms, work tables, parallel bars, training stairs, weight racks, treadmills, and other related equipment. In addition, the company provides clinical supplies, including exercise bands and tubings, lotions and gels, orthopedic bracings, paper products, and other related supplies. It markets its products under the Bird & Cronin, Solaris, Hausmann, Physician's Choice, and PROTEAM brands. The company sells its products to orthopedists, physical therapists, chiropractors, athletic trainers, sports medicine practitioners, clinics, and hospitals, as well as online. It also exports its products to approximately 30 countries. Dynatronics Corporation was founded in 1979 and is headquartered in Eagan, Minnesota.

    NEWS
    https://images.financialmodelingprep.com/news/dynatronics-nasdaqdynt-stock-price-crosses-below-200day-moving-average-20260120.jpg
    Dynatronics (NASDAQ:DYNT) Stock Price Crosses Below 200-Day Moving Average – Here’s Why

    defenseworld.net

    2026-01-20 02:36:56

    Dynatronics Co. (NASDAQ: DYNT - Get Free Report)'s share price passed below its 200-day moving average during trading on Monday. The stock has a 200-day moving average of $0.06 and traded as low as $0.01. Dynatronics shares last traded at $0.01, with a volume of 21,864 shares trading hands. Dynatronics Stock Down 32.9% The company

    https://images.financialmodelingprep.com/news/dynatronics-nasdaqdynt-stock-price-crosses-below-200day-moving-average-heres-20251225.jpg
    Dynatronics (NASDAQ:DYNT) Stock Price Crosses Below 200-Day Moving Average – Here’s Why

    defenseworld.net

    2025-12-25 03:13:03

    Dynatronics Co. (NASDAQ: DYNT - Get Free Report)'s stock price crossed below its 200-day moving average during trading on Wednesday. The stock has a 200-day moving average of $0.07 and traded as low as $0.0455. Dynatronics shares last traded at $0.0455, with a volume of 27,122 shares trading hands. Dynatronics Trading Down 7.7% The company

    https://images.financialmodelingprep.com/news/dynatronics-nasdaqdynt-stock-price-passes-below-two-hundred-day-20251217.jpg
    Dynatronics (NASDAQ:DYNT) Stock Price Passes Below Two Hundred Day Moving Average – Should You Sell?

    defenseworld.net

    2025-12-17 03:44:56

    Dynatronics Co. (NASDAQ: DYNT - Get Free Report) shares crossed below its 200-day moving average during trading on Tuesday. The stock has a 200-day moving average of $0.07 and traded as low as $0.0432. Dynatronics shares last traded at $0.0432, with a volume of 452 shares changing hands. Dynatronics Price Performance The stock has a

    https://images.financialmodelingprep.com/news/dynatronics-corporation-provides-update-regarding-transition-to-otc-markets-20240628.jpg
    Dynatronics Corporation Provides Update Regarding Transition to OTC Markets Group

    newsfilecorp.com

    2024-06-28 08:00:00

    Eagan, Minnesota--(Newsfile Corp. - June 28, 2024) - As previously disclosed, Dynatronics Corporation (NASDAQ: DYNT) ("Dynatronics" or the "Company"), a leading manufacturer of athletic training, physical therapy, and rehabilitation products, received written notice from The Nasdaq Stock Market ("Nasdaq") that if Dynatronics' common stock failed to regain compliance with Nasdaq's minimum bid price requirement before June 24, 2024, the Company's common stock would be delisted from Nasdaq. On June 27, 2024, Dynatronics received written notice from Nasdaq that trading of the Company's common stock will be suspended at the open of business on July 9, 2024 due to Dynatronics' failure to regain compliance with the minimum bid price requirement.

    https://images.financialmodelingprep.com/news/dynatronics-corporation-reports-third-quarter-fiscal-year-2024-financial-20240509.jpg
    Dynatronics Corporation Reports Third Quarter Fiscal Year 2024 Financial Results

    newsfilecorp.com

    2024-05-09 09:00:00

    Eagan, Minnesota--(Newsfile Corp. - May 9, 2024) - Dynatronics Corporation (NASDAQ: DYNT) ("Dynatronics" or the "Company"), a leading manufacturer of athletic training, physical therapy, and rehabilitation products, today reported financial results for its third quarter of fiscal year 2024 ended March 31, 2024. CEO Commentary "We continue to make progress on achieving our sales goals and finding our path to positive EBITDA," said Brian Baker, Chief Executive Officer of Dynatronics.

    https://images.financialmodelingprep.com/news/dynatronics-corporation-schedules-conference-call-to-report-results-for-20240425.jpg
    Dynatronics Corporation Schedules Conference Call to Report Results for Third Quarter Fiscal Year 2024

    newsfilecorp.com

    2024-04-25 08:00:00

    Eagan, Minnesota--(Newsfile Corp. - April 25, 2024) - Dynatronics Corporation (NASDAQ: DYNT) ("Dynatronics" or the "Company"), a leading manufacturer of athletic training, physical therapy, and rehabilitation products, today announced that the Company will release financial results for its third quarter of fiscal year 2024 ended March 31, 2024 on Thursday, May 9, 2024. The Company will subsequently hold a conference call, consisting of prepared remarks by management, and a question-and-answer session with analysts, at 10:00 AM ET on Thursday, May 9, 2024, to review its third quarter fiscal year 2024 results.

    https://images.financialmodelingprep.com/news/why-is-dynatronics-dynt-stock-up-93-today-20240416.png
    Why Is Dynatronics (DYNT) Stock Up 93% Today?

    investorplace.com

    2024-04-16 07:58:50

    Dynatronics (NASDAQ: DYNT ) stock is rocketing higher on Tuesday alongside heavy pre-market trading of the medical device company's shares. This has more than 6 million shares of the company's stock changing hands as of this writing.

    https://images.financialmodelingprep.com/news/dynatronics-corporation-reports-second-quarter-fiscal-year-2024-financial-20240208.jpg
    Dynatronics Corporation Reports Second Quarter Fiscal Year 2024 Financial Results

    newsfilecorp.com

    2024-02-08 06:30:00

    Eagan, Minnesota--(Newsfile Corp. - February 8, 2024) - Dynatronics Corporation (NASDAQ: DYNT) ("Dynatronics" or the "Company"), a leading manufacturer of athletic training, physical therapy, and rehabilitation products, today reported financial results for its second quarter of fiscal year 2024 ended December 31, 2023. CEO Commentary "We continue to make progress on achieving our sales goals and finding our path to positive EBITDA," said Brian Baker, Chief Executive Officer of Dynatronics.

    https://images.financialmodelingprep.com/news/dynatronics-corporation-schedules-conference-call-to-report-results-for-20240125.jpg
    Dynatronics Corporation Schedules Conference Call to Report Results for Second Quarter Fiscal Year 2024

    newsfilecorp.com

    2024-01-25 08:00:00

    Eagan, Minnesota--(Newsfile Corp. - January 25, 2024) - Dynatronics Corporation (NASDAQ: DYNT), a leading manufacturer of athletic training, physical therapy, and rehabilitation products, today announced that the company will release financial results for its second quarter of fiscal year 2024 ended December 31, 2023 on Thursday, February 8, 2024 before the market opens. The company will subsequently hold a conference call, consisting of prepared remarks by management, and a question-and-answer session with analysts, at 8:00 AM ET on Thursday, February 8, 2024, to review its second quarter fiscal year 2024 results.

    https://images.financialmodelingprep.com/news/dynatronics-corporation-announces-andrew-hulett-as-new-board-member-20240115.jpg
    Dynatronics Corporation Announces Andrew Hulett as New Board Member

    newsfilecorp.com

    2024-01-15 08:00:00

    Eagan, Minnesota--(Newsfile Corp. - January 15, 2024) - Dynatronics Corporation (NASDAQ: DYNT), a leading manufacturer of athletic training, physical therapy, and rehabilitation products, today announced the appointment of Andrew Hulett on January 12, 2024 to serve as a member of Dynatronics' Board of Directors to fill the vacancy created by Scott Klosterman's resignation. Erin S. Enright, Chair of the Board of Directors expressed her excitement for Mr.

    https://images.financialmodelingprep.com/news/dynatronics-corporation-reports-first-quarter-fiscal-year-2024-financial-20231109.jpg
    Dynatronics Corporation Reports First Quarter Fiscal Year 2024 Financial Results

    newsfilecorp.com

    2023-11-09 08:30:00

    Eagan, Minnesota--(Newsfile Corp. - November 9, 2023) - Dynatronics Corporation (NASDAQ: DYNT) ("Dynatronics" or the "Company"), a leading manufacturer of athletic training, physical therapy, and rehabilitation products, today reported financial results for its first quarter of fiscal year 2024 ended September 30, 2023. CEO Commentary "We met our sales expectations and were profitable on an EBITDA basis in the first quarter," said Brian Baker, Chief Executive Officer of Dynatronics.

    https://images.financialmodelingprep.com/news/dynatronics-corporation-dynt-expected-to-beat-earnings-estimates-what-20231102.jpg
    Dynatronics Corporation (DYNT) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release

    zacks.com

    2023-11-02 11:18:57

    Dynatronics Corporation (DYNT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

    https://images.financialmodelingprep.com/news/dynatronics-appoints-gabe-ellwein-as-chief-financial-officer-20231030.jpg
    Dynatronics Appoints Gabe Ellwein as Chief Financial Officer

    newsfilecorp.com

    2023-10-30 08:00:00

    Eagan, Minnesota--(Newsfile Corp. - October 30, 2023) - Dynatronics Corporation (NASDAQ: DYNT), a leading manufacturer of athletic training, physical therapy, and rehabilitation products, today announced the appointment of Gabe Ellwein as Chief Financial Officer ("CFO"), effective October 30, 2023. Ellwein will report to the company's President and Chief Executive Officer, Brian Baker, and will lead the company's finance, accounting, and investor relations teams.

    https://images.financialmodelingprep.com/news/dynatronics-corporation-schedules-conference-call-to-report-results-for-20231026.jpg
    Dynatronics Corporation Schedules Conference Call to Report Results for First Quarter Fiscal Year 2024

    newsfilecorp.com

    2023-10-26 08:00:00

    Eagan, Minnesota--(Newsfile Corp. - October 26, 2023) - Dynatronics Corporation (NASDAQ: DYNT), a leading manufacturer of athletic training, physical therapy, and rehabilitation products, today announced that the company will release financial results for its fiscal year first quarter ended September 30, 2023 on Thursday, November 9, 2023. The company will subsequently hold a conference call, consisting of prepared remarks by management, and a question-and-answer session with analysts, at 11:00 AM ET on Thursday, November 9, 2023, to review its first quarter results.

    https://images.financialmodelingprep.com/news/dynatronics-corporation-announces-brian-baker-as-new-chief-executive-20231002.jpg
    Dynatronics Corporation Announces Brian Baker as New Chief Executive Officer and Director

    newsfilecorp.com

    2023-10-02 08:00:00

    Eagan, Minnesota--(Newsfile Corp. - October 2, 2023) - Dynatronics Corporation (NASDAQ: DYNT), a leading manufacturer of athletic training, physical therapy, and rehabilitation products, today announced that on September 29, 2023 its Board of Directors promoted Brian Baker to Chief Executive Officer (CEO) and appointed Mr. Baker to its Board of Directors.